Towards Molecular Classification of Uterine Sarcomas

This presentation will cover recent advances in uterine sarcoma classification with emphasis on genotype-phenotype correlation and possible therapeutic implications. Discussion will include recognition of novel uterine sarcoma subtypes, application of molecular techniques in uterine sarcoma diagnosis, and therapeutic biomarkers.

Lecture Presenter
Image
Sarah Chiang, MD
Sarah Chiang, MD
Pathologist, Memorial Sloan Kettering Cancer Center

Dr. Sarah Chiang is a board-certified surgical pathologist with clinical expertise in gynecologic and obstetric pathology. Prior to joining the Memorial Sloan Kettering Cancer Center faculty in 2013, Dr. Chiang completed a residency in anatomic pathology, as well as the Robert E. Scully fellowship in gynecologic, obstetric, and urologic pathology at Massachusetts General Hospital, a teaching hospital of Harvard Medical School.

Objectives

After this presentation, participants will be able to:

Recognize histologic, immunohistochemical and molecular features of novel uterine sarcoma subtypes
Assess the utility of various molecular methods in uterine sarcoma diagnosis